Clinical trial
Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema
NCT00476918 · Heidelberg University, Other · Unknown status
Key facts
| NCT number | NCT00476918 |
|---|---|
| Title | Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema |
| Official title | Dosage Dependency of Intravitreal Triamcinolone Acetonide for Treatment of Diabetic Macular Edema |
| Lead sponsor | Heidelberg University, Other |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Diabetic Retinopathy, Diabetic Macular Edema |
| Intervention type | Drug |
| Interventions | Intravitreal injection (triamcinolone acetonide) |
| Enrollment | 60 |
| Start date | Jul 1, 2006 |
| Completion | Dec 1, 2007 |
| First posted | May 22, 2007 |
| Last update posted | May 22, 2007 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: